Showing 1 - 3 results of 3 for search 'R. Marasca', query time: 0.02s Refine Results
  1. 1
    LA DIAGNOSI DI INFEZIONE TUBERCOLARE LATENTE IN PAZIENTI CON EMOLINFOPATIE MALIGNE: USO DEI TEST IMMUNOLOGICI.

    LA DIAGNOSI DI INFEZIONE TUBERCOLARE LATENTE IN PAZIENTI CON EMOLINFOPATIE MALIGNE: USO DEI TEST IMMUNOLOGICI. by M. Losi, M. Meacci, F. Luppi, A. Ferrari, R. D’Amico, S. Cerri, P. Roversi, B. Meccugni, I. Marchetti Dori, R. Caracciolo, R. Marasca, M. Luppi, G. Torelli, L.M. Fabbri, L. Richeldi, F. Rumpianesi

    Published 2007-09-01
    Get full text
    Article
  2. 2
    S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB VERSUS IMATINIB WITH EARLY SWITCH TO NILOTINIB TO OBTAIN SUSTAINED TREATMENT-FREE REMISSION IN PATIENTS WITH WITH CHRONIC MYELOID LEUKEMIA

    S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB VERSUS IMATINIB WITH EARLY SWITCH TO NILOTINIB TO OBTAIN SUSTAINED TREATMENT-FREE REMISSION IN PATIENTS WITH WITH CHRONIC... by F. Pane, F. Castagnetti, L. Luciano, A. Russo Rossi, E. Abruzzese, R. Bassan, G. Binotto, G. Caocci, G. Cimino, P. Fazi, A. Gozzini, M. Lunghi, R. Marasca, B. Martino, M. Bonifacio, F. Cavazzini, F. Paoloni, G. Saglio, S. Sica, A. Tafuri, D. Vallisa, M. Vignetti, P. Westerweel, G. Rosti, M. Breccia

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE

    P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE by R. Bomben, F. M. Rossi, F. Vit, T. Bittolo, A. Zucchetto, R. Papotti, E. Tissino, F. Pozzo, M. Degan, E. Zaina, I. Cattarossi, P. Nanni, R. Marasca, G. Reda, L. Laurenti, J. Olivieri, A. Chiarenza, L. Ballotta, A. Cuneo, M. Gentile, F. Morabito, A. Tafuri, F. Zaja, R. Foà, F. Di Raimondo, G. Del Poeta, V. Gattei

    Published 2022-06-01
    Get full text
    Article

Search Tools: